Syros Pharmaceuticals - SYRS Expected Profit

Public company logo of syros.com (SYRS)

Syros Pharmaceuticals (SYRS) relies on a lean R&D model by outsourcing substance synthesis to external contractors. This consensus earnings forecast chart reflects market expectations, where the figure is fixed at . A patent shield on biomarkers serves as a defensive asset, although there is currently no cash flow as the development of genetic platforms remains in the clinical trial stage.

syros.com (SYRS): Company Profit Forecast from 07/04/2022 to 11/17/2026

Syros (SYRS) - metric breakdowns and financial figures

Fundamental company valuation:syros.com, SYRS
Core merchandise of Syros Pharmaceuticals Inc.

This indicator reflects the dynamics of expected net income, allowing for the differentiation between a market correction and a fundamental devaluation of the business. Analysis of the planned profit trend reveals the company's resilience to external shocks through the stability of daily calculations. The metric measures the probability of capitalization recovery, signaling margin degradation during a prolonged decline. For Syros Pharmaceuticals (SYRS), this confirms the effectiveness of its scientific portfolio management. Prudent capital expenditure on genetic control in oncology minimizes the risk of a long-term investment freeze.

Main competitors

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Projected Net Profit Nautilus Biotechnology, Inc. (NAUT)|MGX: Projected Future Earnings|Net Profit Forecast DTIL|GBIO (Generation Bio) - Projected Future Earnings|Net Profit Forecast BOLD (boundlessbio.com)|Future Profit XCUR (exicuretx.com)|Celsion Corporation - Net Profit Forecast|Projected Future Earnings PHIO (phiopharma.com)|Projected Future Earnings Mustang Bio, Inc. MBIO|RNAZ: Future Profit|BNGO (Bionano Genomics) - Net Profit Forecast|APDN: Projected Future Earnings|bluebird bio (BLUE) - Projected Future Earnings|Expected Profit ImmunoPrecise Antibodies Ltd.|Expected Net Profit Omega OMGA|Projected Future Earnings OMIC|RGLS - Expected Net Profit|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings